1995
DOI: 10.1001/archderm.131.4.432
|View full text |Cite
|
Sign up to set email alerts
|

Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
1
4

Year Published

2003
2003
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(24 citation statements)
references
References 0 publications
0
20
1
4
Order By: Relevance
“…A high rate of melanoma was found in patients with cutaneous T cell lymphoma 12–95 months after receiving total skin electron beam therapy [27]. In other reports, a female patient developed melanoma on the back 10 years after 50 Gy of 60 Co γ-irradiation for endometrial carcinoma [28].…”
Section: Discussionmentioning
confidence: 99%
“…A high rate of melanoma was found in patients with cutaneous T cell lymphoma 12–95 months after receiving total skin electron beam therapy [27]. In other reports, a female patient developed melanoma on the back 10 years after 50 Gy of 60 Co γ-irradiation for endometrial carcinoma [28].…”
Section: Discussionmentioning
confidence: 99%
“…Myelosuppression is not observed. While the risk of secondary nonmelanoma skin cancers following topical mechlorethamine alone is debatable, it may potentiate the carcinogenic affects of other therapies [208]. Topical BCNU (carmustine) is associated with complete remission rates exceeding 80% following a median of 3 months of therapy.…”
Section: Treatment Of Limited-stage Mfmentioning
confidence: 99%
“…11,22 Smaller case reports, however, have reported this relationship. [23][24][25] These studies included cases in which melanoma was diagnosed either before or after MF, whereas other studies only considered second cancers diagnosed after MF diagnosis. Patients with MF are possibly at increased risk for melanoma as a result of the various topical treatments for MF; for example, an increased incidence of melanoma has been found in patients who receive oral methoxsalen (psoralen) and UV-A radiation therapy or other skin-damaging agents used to treat MF and SS.…”
Section: Commentmentioning
confidence: 99%